Oncaspar OverviewPegaspargase /pæsprez/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The drug is manufactured by Exelead, Inc. It is used in the treatment of acute lymphoblastic leukemia. See also PEGylation References ^ "UNM Cancer Center". Archived from the original on September 3, 2006. Retrieved 2007-08-28. ^ Graham ML (2003). "Pegaspargase: a review of clinical studies". Adv. Drug Deliv. Rev....
Read more Oncaspar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaspargase
Recent Oncaspar Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 750IU/ml
- Vial: 750iu/vial
NDC Database Records for Oncaspar: (2 results)Sorted by National Drug Code
- 0944-3810 Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution by Baxalta Us Inc.
- 54482-301 Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, Solution by Sigma-tau Pharmaceuticals, Inc.